Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Repare Therapeutics Inc
(NQ:
RPTX
)
3.010
+0.040 (+1.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Repare Therapeutics Inc
< Previous
1
2
3
Next >
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 08, 2024
Via
Benzinga
Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
May 08, 2024
Via
Benzinga
Recap: Repare Therapeutics Q4 Earnings
February 28, 2024
Via
Benzinga
Recap: Repare Therapeutics Q3 Earnings
November 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 08, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 08, 2024
We're diving into the biggest pre-market stock movers for Wednesday will a look at all of the latest news happening this morning.
Via
InvestorPlace
RPTX Stock Earnings: Repare Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
RPTX stock results show that Repare Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients
April 15, 2024
Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + GemOx vs. Rituxan + GemOx.
Via
Benzinga
Wall Street Thinks This Cathie Wood Stock Could Jump by 187%
August 16, 2023
This small-cap biotech stock holds enormous growth potential.
Via
The Motley Fool
Analyst Expectations for Repare Therapeutics's Future
June 09, 2023
Via
Benzinga
Recap: Repare Therapeutics Q1 Earnings
May 09, 2023
Via
Benzinga
Analyst Expectations for Repare Therapeutics's Future
April 27, 2023
Via
Benzinga
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
February 13, 2024
Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved.
Via
Benzinga
These Biotech Stocks Could Double Your Money, According To Analysts
November 09, 2023
Via
Benzinga
$2.8M Bet On Repare Therapeutics? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
November 06, 2023
The Dow Jones closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 10, 2023
Via
Benzinga
4 Analysts Have This to Say About Repare Therapeutics
April 27, 2023
Via
Benzinga
Repare Therapeutics's Return On Capital Employed Insights
December 16, 2022
Via
Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2023
June 09, 2023
Via
Benzinga
Repare Therapeutics Releases Early Anticancer Activity From Its Monotherapy, Combination Trials
June 08, 2023
Repare Therapeutics Inc (NASDAQ: RPTX) reported initial proof of concept monotherapy data from its Phase 1 MYTHIC trial evaluating lunresertib (RP-6306) in molecularly selected
Via
Benzinga
Cathie Wood Has Been Building Stakes In Two Little-Known Stocks
February 10, 2023
Cathie Wood – the billionaire investor who recently called her flagship fund “the new Nasdaq” has been loading up on shares of the following two small-cap stocks in recent days.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via
Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
November 25, 2022
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday
November 17, 2022
Via
Benzinga
Biotech ETF Tops in June: 5 Stocks That Outperform
June 30, 2022
Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%.
Via
Talk Markets
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
June 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
United Airlines And 3 Other Stocks Insiders Are Buying
June 07, 2022
Although US stocks closed slightly higher on Monday, there were a few notable insider trades.
Via
Benzinga
74 Biggest Movers From Yesterday
June 03, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.